SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-436840
Filing Date
2013-11-12
Accepted
2013-11-12 07:01:17
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d595042d10q.htm 10-Q 526751
2 EX-31.1 d595042dex311.htm EX-31.1 6756
3 EX-31.2 d595042dex312.htm EX-31.2 6759
4 EX-32.1 d595042dex321.htm EX-32.1 4338
5 EX-32.2 d595042dex322.htm EX-32.2 4335
  Complete submission text file 0001193125-13-436840.txt   4111554

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srpt-20130930.xml EX-101.INS 499878
7 XBRL TAXONOMY EXTENSION SCHEMA srpt-20130930.xsd EX-101.SCH 38009
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20130930_cal.xml EX-101.CAL 51391
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20130930_def.xml EX-101.DEF 151089
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20130930_lab.xml EX-101.LAB 345964
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20130930_pre.xml EX-101.PRE 256442
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 131206881
SIC: 2834 Pharmaceutical Preparations